Sandip Kapadia - 30 Sep 2024 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol: HRMY
Transactions as of: 30 Sep 2024
Net transactions value: -$1,282,080
Form type: 4
Filing time: 02 Oct 2024, 16:04:07 UTC
Previous filing: 23 May 2024
Next filing: 23 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$0	+60,000		$0.000000	60,000	30 Sep 2024	Direct
transaction	HRMY	Common Stock	Tax liability	$1,282,080	-32,052	-53%	$40.00	27,948	30 Sep 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Restricted Stock Units	Options Exercise	$0	-60,000	-40%	$0.000000	90,000	30 Sep 2024	Common Stock	60,000		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2	This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.